Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II intermittent letrozole as adjuvant endocrine therapy in postmenopausal hormone receptor-positive early breast cancer
2007-002059-18Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of letrozole in breast cancer, sponsored by European Institute of Oncology. Started Aug 2007; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002059-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002059-18.